Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN - Wikidata - awgldk - TriplyDB

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN

http://www.wikidata.org/entity/Q37148392

about

Phosphatase and Tensin Homologue: Novel Regulation by Developmental Signaling Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer MicroRNAs: novel players in cancer diagnosis and therapies.Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel.MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN).miRNA - Therapeutic tool in breast cancer? Where are we now?Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and Chemotherapy MicroRNAs: short non-coding players in cancer chemoresistance.Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer MicroRNA in Cancer and Cachexia--A Mini-Review Oncogenic cooperation between SOCS family proteins and EGFR identified using a Drosophila epithelial transformation model.Contextual Refinement of Regulatory Targets Reveals Effects on Breast Cancer Prognosis of the Regulome Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met Small molecules targeting microRNA for cancer therapy: Promises and obstacles.Role of microRNAs in breast cancer.Identification of candidate genes encoding an LDL-C QTL in baboons Noncoding RNAs in breast cancer.MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression.Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion.MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications.Epigenetic regulation of mmp-9 gene expression.MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.Friend or foe: the role of microRNA in chemotherapy resistance.The role of microRNA in resistance to breast cancer therapy.Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells.miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells MiR-139-5p: promising biomarker for cancer.miR-19a and miR-19b overexpression in gliomas.Non-coding RNAs in Mammary Gland Development and Disease.Development of MicroRNA Therapeutics for Hepatocellular Carcinoma.Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer.MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition.miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.MicroRNAs in melanoma development and resistance to target therapy.MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells.MiR-92a regulates viability and angiogenesis of endothelial cells under oxidative stress.HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL.

P2860

Q26784590-269ECD98-F665-4B1C-AF38-C0A7D059F81E Q28066481-7781CA8F-E696-4997-9756-0B50532AFB7A Q33552969-4D89E08B-8E53-42CB-977E-E2147C1C6059 Q33914573-D4606397-DC64-4136-9315-9C328FF1E377 Q34066078-B2392E6A-170D-4381-895D-2B57C3FFA899 Q34436329-002FBCA6-0589-4AE8-B21A-9AF9D081D34C Q35113386-F23D1CE3-27FB-44BB-9EF4-E9EF5FD379CA Q35647187-34513FDC-8710-4702-8691-AE4992A8EA31 Q35673637-C3FB3480-4E23-40A7-A5AF-52F35D88DA77 Q35802368-543266F8-7A1A-4163-ADD2-E98DF8743813 Q35863159-34E08835-5599-4216-9422-B195CAAFC899 Q36071904-8BAEE723-2C3F-41C1-916D-C6A3B26F827A Q36114096-7553FE56-5FBE-4C3A-935D-B1F36A2CD949 Q36253768-910FE813-6EF9-4B86-A773-D7831EFC1F35 Q36545471-A8361BEA-4928-48B7-BC35-0BA077C1F095 Q36567511-B9D3FFB8-C228-40EC-819B-72142C36D9B3 Q36677690-590C4781-95F0-436B-A421-9A97896A9049 Q36920553-DFB0C66C-F393-4BAB-9DBD-BB784DBF8957 Q36935047-74DF3E03-DFB0-4A2C-A09A-4804FED37BCE Q37452145-9ACD8AB8-B9E8-4B95-90D1-332DD6614095 Q37699535-D3A07677-C88C-4A16-9AB7-D3CABFBFCEE3 Q38036917-F9F8830C-E5F1-4EFE-8C3D-1C6328BB9549 Q38062851-4504D19E-F273-4BE3-91D1-C8085FCBF068 Q38097384-1F7B35C7-191A-4EBF-8FA7-7E6008053103 Q38102553-0ABF4E6D-758E-4FBE-AE0B-A3B7F2A729D2 Q38231981-2CCF5F5B-5C26-4F34-86B0-3CC5D734EDF3 Q38272241-06708F23-FB08-45E5-8960-8D0556EE1F1C Q38301306-C591E912-E94B-4C01-9AFA-20DB78A06C9C Q38359431-BBE65187-AA9C-40F9-9DB5-34AAE44CB566 Q38395794-E41A2641-DE89-4366-A828-938FB30549B8 Q38667231-B8AB83F2-9C38-4163-B031-765B4CE83144 Q38719441-E62121C7-278B-4B59-846A-51163C534156 Q38841033-1F03AA7F-65D3-431B-885F-E33DE64A2180 Q38861308-01EC8FB3-4887-4227-9EA9-727B75302188 Q38883702-86B5A99A-EBD3-45D5-ADC8-43D7ED73FF94 Q39101272-65F0F105-68FD-40E8-915F-52D012296951 Q39112720-D30A2255-F65E-4A1B-978D-55A2D38E5F05 Q39371337-B31224C7-3378-4BED-9BEB-15E666CD466B Q39470921-533F35F4-1023-441F-9F10-B487511A4C6A Q47385628-257FB314-169F-4289-858E-A36556613EA0

P2860

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN

http://www.wikidata.org/entity/Q37148392

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 August 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN

@en

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN.

@nl

type

label

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN

@en

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN.

@nl

prefLabel

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN

@en

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN.

@nl

P1433

Q37148392-97C0DF36-BE8D-416C-944C-0D21015DA499

P1476

Q37148392-2A67CB45-8962-4B66-802E-1068BDEFE7E6

P2093

Q37148392-45FDAF20-A4E7-4033-B943-48CC9EB4FF91

Q37148392-4DE82E3F-6B11-4A01-8FF5-FD06482DD0B5

Q37148392-5F8EDFEA-C387-474D-8979-AFAC646241DE

Q37148392-7D0A330D-07DD-41DB-B804-8CBD746A6B05

Q37148392-D6A036E5-24E5-4AB7-AC76-35860DD8759C

P2860

Q37148392-1900EAF3-6D70-4FEC-A7D1-538A98867F23

Q37148392-19AC90B6-3870-4E2B-9706-5940DD2938B0

Q37148392-1E14561A-0928-4B97-B6D3-5617428393A1

Q37148392-2217C7BC-7731-4B6A-B311-00C50F25A261

Q37148392-2270A84F-6963-4166-940F-A9A9F02E02DE

Q37148392-23AD394F-5C25-4F76-84A7-8BC545F3ED79

Q37148392-28DE56D7-647D-495A-81A1-4641B5176FDC

Q37148392-34BBA0FE-443D-4512-B71D-5D3B7F36293C

Q37148392-374DE4DA-2B00-4706-9940-BA5D38229919

Q37148392-3EAC6C86-7FB8-48A1-8611-910EBE471C49

P304

Q37148392-85D16EDC-DB41-4CE7-A649-651FA3976EEA

P31

Q37148392-50701F9A-B640-4E60-8073-65768ED1E3B3

P356

Q37148392-1FFE2CD4-58C2-43D8-877C-520D7DA7DB67

P433

Q37148392-70709C09-461A-4C10-AED2-94019944F795

P478

Q37148392-846DF204-6F2D-43FC-8C5D-80CBB669BA43

P577

Q37148392-23303D5C-5CD5-4053-A5C5-413D0D880828

P698

Q37148392-812849EF-1068-450B-9580-777E5E2651F7

P932

Q37148392-7A6AFB55-5D17-4915-AD6D-629933D20C38

P356

S11095-011-0570-Y

P1433

Pharmaceutical Research

P1476

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN

@en

P2093

Hyunsuk Shim

http://www.w3.org/2001/XMLSchema#string

Ke Huang

http://www.w3.org/2001/XMLSchema#string

Nicholas Wagar

http://www.w3.org/2001/XMLSchema#string

Yuhua Li

http://www.w3.org/2001/XMLSchema#string

Zhongxing Liang

http://www.w3.org/2001/XMLSchema#string

P2860

miR-15 and miR-16 induce apoptosis by targeting BCL2

Improved targeting of miRNA with antisense oligonucleotides

The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

miR-19 is a key oncogenic component of mir-17-92

Real-time expression profiling of microRNA precursors in human cancer cell lines.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer.

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

MicroRNA signatures in human cancers

P304

3091-3100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-011-0570-Y

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21853360

http://www.w3.org/2001/XMLSchema#string

P932

3763502

http://www.w3.org/2001/XMLSchema#string